Our Pricing

Your First Week Starting Mounjaro Treatment

Published on: June 03, 2026

The first week starting Mounjaro UK treatment sets the foundation for your weight loss journey. At Cured Pharmacy, we provide genuine UK-licensed Mounjaro from £124.99 with comprehensive support from our clinical team led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073). This guide walks you through exactly what to expect during your initial seven days on tirzepatide therapy.

Understanding Your First Week Starting Mounjaro Dose

Your first Mounjaro injection will be 2.5mg, the lowest maintenance dose designed to help your body gradually adjust to tirzepatide. This starting dose is not intended to produce maximum weight loss—rather, it minimises side effects whilst your system adapts to the medication's dual GIP/GLP-1 receptor activity [1].

Clinical trials demonstrate that this gradual dose escalation approach significantly reduces gastrointestinal side effects compared to starting at higher doses. The SURPASS-1 trial showed that patients who followed the recommended titration schedule experienced 40% fewer treatment discontinuations due to adverse events [1].

You'll remain on the 2.5mg dose for four weeks before your prescriber assesses whether to increase to 5mg. This patient-specific approach ensures tolerability whilst building towards the therapeutic doses that produced an average 22.5% body weight reduction in the SURPASS-3 trial [2].

What the 2.5mg Starter Dose Does

Even at 2.5mg, you may notice reduced appetite and earlier satiety within the first week. Tirzepatide begins slowing gastric emptying and modulating appetite-regulating hormones immediately, though full therapeutic effects develop over subsequent weeks as you progress through higher doses [1].

How to Inject Mounjaro: First Week Technique

The Mounjaro KwikPen is a pre-filled, single-dose injection device designed for subcutaneous administration. Before your first injection, allow the pen to reach room temperature for 30 minutes—cold injections can cause unnecessary discomfort and may affect absorption rates.

Choose an injection site on your abdomen (at least 5cm away from your navel), upper thigh, or upper arm. Rotate injection sites weekly to prevent lipohypertrophy, a condition where repeated injections in the same area cause lumpy tissue that impairs medication absorption [3]. Clean the site with an alcohol wipe and allow it to dry completely.

Remove the pen cap, position the device at a 90-degree angle against your skin, and press firmly until you hear a click. Hold the pen in place for 10 seconds to ensure complete dose delivery—the viewing window will turn from clear to grey when the injection is complete. Dispose of used pens in a sharps container, which your pharmacy should provide.

Timing Your First Injection

Administer Mounjaro once weekly on the same day each week, at any time of day, with or without food. Many patients prefer weekend mornings when they can monitor for side effects without work commitments. Choose a consistent day you'll remember—setting a phone reminder helps maintain the weekly schedule that optimises therapeutic outcomes [1].

Common Side Effects in Your First Week Starting Mounjaro

Nausea is the most frequently reported side effect during the first week, affecting approximately 25-30% of patients starting tirzepatide therapy. This typically manifests as mild queasiness rather than severe nausea, and usually subsides within 3-5 days as your body adjusts to the medication [1].

Other common first-week experiences include reduced appetite (often welcomed by patients), mild abdominal discomfort, occasional diarrhoea, and fatigue. These effects are generally transient and resolve as your GI system adapts to slower gastric emptying. In clinical trials, fewer than 5% of patients discontinued treatment due to gastrointestinal side effects during the initial titration phase [2].

Contact your prescriber immediately if you experience severe abdominal pain, persistent vomiting, signs of pancreatitis, or allergic reactions. Whilst serious adverse events are rare, prompt medical assessment ensures appropriate management and treatment continuation decisions.

Managing First Week Nausea

Eat smaller, more frequent meals rather than three large meals. Avoid high-fat, greasy, or spicy foods that exacerbate nausea. Stay well-hydrated with small sips of water throughout the day. Ginger tea and bland foods like crackers or toast can help settle your stomach. If nausea persists beyond the first week or significantly impacts your quality of life, consult your prescriber—dose adjustments or anti-nausea medications may be appropriate [3].

Dietary Adjustments During Week One

Your appetite will likely decrease noticeably during the first week as tirzepatide activates GLP-1 receptors in your brain's appetite control centres. This is the medication working as intended—do not force yourself to eat if you're not hungry, but ensure you're meeting minimum nutritional requirements.

Focus on protein-rich foods to preserve lean muscle mass during weight loss. Aim for 60-80g of protein daily from sources like chicken, fish, eggs, Greek yoghurt, and legumes. Adequate protein intake is associated with better body composition outcomes and reduced loss of muscle tissue during calorie restriction [4].

Reduce portion sizes naturally in response to satiety signals. Many patients find they feel satisfied with 50-60% of their usual portion sizes. Eat slowly, chewing thoroughly, as rapid eating can trigger nausea when gastric emptying is slowed. Prioritise nutrient-dense foods over empty calories to ensure adequate vitamin and mineral intake despite reduced food volume.

What Weight Loss to Expect in Week One

During your first week on the 2.5mg starter dose, expect modest weight changes—typically 0.5-1.5kg. Some of this initial loss is water weight as your body adjusts to reduced food intake and changes in fluid retention. Significant weight loss occurs during later weeks as you progress to higher therapeutic doses.

The SURPASS trials demonstrated that average weight loss follows a dose-dependent pattern, with minimal changes at 2.5mg and progressive increases at 5mg, 10mg, and 15mg doses. Patients who achieved the highest weight reductions (averaging 22.5% body weight) did so over 72 weeks, not during the first month [2].

Avoid daily weigh-ins during week one, as normal fluctuations in water retention, bowel movements, and food timing can mask actual fat loss trends. Weekly weigh-ins on the same day, at the same time, using the same scale provide more meaningful data for tracking progress.

Mounjaro Treatment at Cured Pharmacy

Cured Pharmacy supplies genuine UK-licensed Mounjaro KwikPens from £124.99 dispensed following clinical assessment by our UK-registered prescribers. Our transparent pricing model shows costs upfront—before your consultation—so you can make informed decisions about your weight loss treatment.

Every Mounjaro prescription begins with a comprehensive online consultation taking under three minutes. Our clinical team, led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), reviews your medical history, current medications, and weight loss goals to determine suitability. All assessments comply with MHRA prescribing guidelines and GPhC standards.

We provide discreet packaging, next-day delivery options, and ongoing clinical support throughout your treatment journey. As a GPhC-registered pharmacy (9012511), we dispense only genuine medicines sourced through licensed UK wholesalers. If you have questions during your first week or any subsequent treatment phase, our pharmacy team is available at (+44) 116 4646009.

Starting Your Mounjaro Assessment

Complete your free online consultation today to determine if Mounjaro is appropriate for your weight loss goals. Our prescribers assess eligibility based on BMI, medical history, previous weight loss attempts, and contraindications. If approved, your prescription is dispensed immediately with delivery typically within 1-2 working days across the UK.

Scientific References

1. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
2. Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583-598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. https://products.mhra.gov.uk/ [accessed 13 August 2026]
4. Pasiakos, S. M., Cao, J. J., Margolis, L. M., et al. (2013). Effects of high-protein diets on fat-free mass and muscle protein synthesis following weight loss: a randomized controlled trial. The FASEB Journal, 27(9), 3837-3847. https://doi.org/10.1096/fj.13-230227 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence, diet, and physical activity.